Brain-Derived Neurotrophic Factor Levels in Mesenchymal Stem Cell Culture Fluid Under Different Culture Conditions

被引:0
|
作者
Cicek, Gulsemin [1 ]
Cicek, Muharrem [2 ]
Ozen, Emine Utlu [3 ]
Aktan, T. Murad [4 ]
Ozdengul, Faik [5 ]
Duman, Selcuk [4 ]
机构
[1] Basaksehir Cam & Sakura City Hosp, Dept Histol & Embryol, Istanbul, Turkiye
[2] Kanuni Sultan Suleyman Training & Res Hosp, Dept Pediat, Istanbul, Turkiye
[3] Etlik Zubeyde Hanim Womens Hlth Training & Res Ho, Dept Histol & Embryol, Ankara, Turkiye
[4] Necmettin Erbakan Univ, Meram Fac Med, Dept Histol & Embryol, Konya, Turkiye
[5] Necmettin Erbakan Univ, Meram Fac Med, Dept Physiol, Konya, Turkiye
来源
EURASIAN JOURNAL OF MEDICINE | 2023年 / 55卷 / 01期
关键词
Mesenchymal stem cell; culture fluid; brain-derived neurotrophic factor; hypoxia; microcarrier; BDNF LEVELS; FUTURE; NEUROPROTECTION; TRANSPLANTATION; GROWTH;
D O I
10.5152/eurasianjmed.2021.0138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Mesenchymal stem cells are used in various fields, such as cellular therapy, regeneration, or tissue engineering. It has been shown that they exhibit many protective factors and also work as a modulating chief within the region in which they are administered. There are studies on both the therapeutic and neuroprotective effects of brain-derived neurotrophic factor. Also, there are many studies on the improvement of culture conditions for in vitro reproduction of mesenchymal stem cells, which can be obtained from many sources in various bodies, such as adipose tissue and Wharton's jelly. Improving and standardizing these culture conditions will increase the effectiveness and reliability of stem cell therapies. Studies evaluating many culture conditions, such as O-2 level, type of medium, monolayer culture, and the transition from in vitro 3D models, are ongoing. Materials and Methods: In our study, groups were formed by using stem cells originating from adipose tissue and Wharton's jelly. Stem cell cultures were made using Hillex-II and Pronectin-F microcarriers. Cell culture O-2 level was adjusted as 1% and 5% for each group separately. Enzyme-linked immunosorbent assay was used to analyze brain-derived neurotrophic factor levels in stem cell culture fluid. Results: The highest brain-derived neurotrophic factor level in mesenchymal stem cells culture medium was observed in an adipose-derived stem cell culture with an in vitro fertilization (non-treated) dish, using a Hillex microcarrier in a 1% O 2 microenvironment. Conclusion: As a result of our observations, we think that cells could exhibit greater therapeutic potential in a dynamic adhesion environment.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [41] Brain-Derived Neurotrophic Factor (BDNF) As a Regulator of Apoptosis under Conditions of Focal Experimental Stroke
    S. G. Kalinichenko
    N. Y. Matveeva
    A. V. Korobtsov
    Bulletin of Experimental Biology and Medicine, 2020, 169 : 701 - 706
  • [42] Serum levels of brain-derived neurotrophic factor in Sydenham’s chorea
    Antônio Lúcio Teixeira
    Thales Lage Bretas
    Arthur Kummer
    Lívia Cunha Melo
    Amanda Baraldi
    Estefânia Harsányi
    Francisco Cardoso
    Elizabeth Ribeiro da Silva Camargos
    Neurological Sciences, 2010, 31 : 399 - 401
  • [43] SERUM AND URINARY LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IN ENURESIS
    Kurku, Huseyin
    Soran, Mustafa
    Yar, Ahmet
    Akdam, Neriman
    Arslan, Sukru
    Gonen, Murat
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (10): : 1032 - 1037
  • [44] Serum levels of brain-derived neurotrophic factor in Sydenham's chorea
    Teixeira, Antonio Lucio
    Bretas, Thales Lage
    Kummer, Arthur
    Melo, Livia Cunha
    Baraldi, Amanda
    Harsanyi, Estefania
    Cardoso, Francisco
    da Silva Camargos, Elizabeth Ribeiro
    NEUROLOGICAL SCIENCES, 2010, 31 (03) : 399 - 401
  • [45] Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet
    Guimaraes, Lisia Rejane
    Jacka, Felice N.
    Gama, Clarissa Severino
    Berk, Michael
    Leitao-Azevedo, Carmen Lucia
    Belmonte de Abreu, Martha Guerra
    Lobato, Maria Ines
    Andreazza, Ana Cristina
    Cereser, Keila Maria
    Kapczinski, Flavio
    Belmonte-de-Abreu, Paulo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06): : 1595 - 1598
  • [46] Brain-derived neurotrophic factor plasma levels in patients with Turner syndrome
    Czyzyk, Adam
    Casarosa, Elena
    Luisi, Michele
    Podfigurna-Stopa, Agnieszka
    Meczekalski, Blazej
    Genazzani, Andrea Riccardo
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (03) : 245 - 249
  • [47] Serum levels of brain-derived neurotrophic factor in patients with acne vulgaris
    Mikhael, Nancy W.
    Hamed, Ahmed M.
    Mansour, Amira I.
    Abdelrahman, Eman S.
    JOURNAL OF COSMETIC DERMATOLOGY, 2019, 18 (06) : 1998 - 2003
  • [48] Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus
    Greenwood, B. N.
    Strong, P. V.
    Foley, T. E.
    Thompson, R. S.
    Fleshner, M.
    NEUROSCIENCE, 2007, 144 (04) : 1193 - 1208
  • [49] Decreased Serum Brain-Derived Neurotrophic Factor Levels in Seizure Patients
    Leaver, Katherine E.
    LaFrance, W. Curt, Jr.
    ANNALS OF NEUROLOGY, 2009, 66 : S16 - S16
  • [50] Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients
    Brunoni, A. R.
    Lotufo, P. A.
    Sabbag, C.
    Goulart, A. C.
    Santos, I. S.
    Bensenor, I. M.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (08) : 711 - 714